Briacell Therapeutics Corp BCTX

$4.02 -0.16 (-3.83%)

Valuation

Market cap
36,365,000
Revenue TTM
$0
Net income TTM
$-26,310,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
69,100
Avg volume
325,750
Day's range
$3.99 – $4.22
Shares out
8,700,000
Stochastic %K
17%
Beta
1.21
Analysts
Strong Buy
Price target
$40.00

Price

Company profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator...

Show more

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 921 1810
Website
https://briacell.com
Address
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

Latest news

Stocktwits

Rohtan Oct 7, 12:58 AM
$BCTX
1 replies
DunkenInvest Oct 6, 5:29 PM
$BCTX I really need some action on this ticker. Dont care if its 50% up or down, I'm just bored of looking at 4$ Give me 2$ and ill buy like crazy, or give me 6$ and I'm a happy man. Either goes wild for me 🤷🏼
6 replies
SmallCapGrowth Oct 6, 5:15 PM
🔥 $BCTX IS HEADING TO SITC 2026 4 abstracts selected. 4 poster presentations. Multiple immunotherapy programs. BriaCell → Bria-OTS+ BriaPro → BP-80 + checkpoint inhibitors + CD80 variants NEWS: https://bit.ly/4yyIRl0 #Biotech #CancerResearch
0 replies
SmallCapGrowth Oct 6, 4:16 PM
$BCTX BriaCell and BriaPro are bringing research across multiple immunotherapy technologies to SITC 2026. From Bria-OTS+ to BP-80 and engineered CD80 variants, the company is showcasing a broad research pipeline. NEWS https://bit.ly/4yyIRl0 #BiotechStocks #Immunotherapy
0 replies
Merlintrader Oct 6, 3:59 PM
Latest company news, October 6: four preclinical posters accepted at SITC 2026 (November 4-8), one from BriaCell on Bria-OTS+ and three from its subsidiary BriaPro. BriaCell ($BCTX) Stock Hub: When Does The Phase 3 Interim Actually Arrive? Explore the company, catalysts and risks in our research hub. https://www.merlintrader.com/briacell-therapeutics-stock-hub/
0 replies
SmallCapGrowth Oct 6, 3:45 PM
$BCTX expands its presence at SITC - HOT HOT PENNY https://investorshangout.com/post/view?id=6847350
0 replies
SmallCapGrowth Oct 6, 3:42 PM
$BCTX expands its presence at SITC 2026 with 4 poster presentations across BriaCell and BriaPro programs, highlighting the depth of its immunotherapy pipeline. NEWS: https://bit.ly/4yyIRl0 #Oncology #HealthcareStocks #SmallCapStocks #SITC2026 #BreastCancer #Investing #Biotech
0 replies
SmallCapGrowth Oct 6, 3:33 PM
Emerging Penny Stocks : $BCTX investors should have SITC 2026 on... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=178019762 via @Investors_Hub
0 replies